- Home
- RRX vs ELAN Comparison
RRX vs ELAN Comparison
Compare RRX & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRX | ELAN |
|---|---|---|
| Founded | 1955 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.7B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RRX | ELAN |
|---|---|---|
| Price | $208.73 | $23.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $210.70 | $27.89 |
| AVG Volume (30 Days) | 996.2K | ★ 4.3M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | ★ 42.86 | N/A |
| EPS | ★ 4.20 | N/A |
| Revenue | $3,257,100,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $4.15 | $8.21 |
| Revenue Next Year | $12.25 | $5.31 |
| P/E Ratio | $48.97 | ★ N/A |
| Revenue Growth | 5.21 | ★ 6.22 |
| 52 Week Low | $98.15 | $8.59 |
| 52 Week High | $229.30 | $27.72 |
Technical Indicators
Market Signals| Indicator | RRX | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 48.86 |
| Support Level | $136.55 | $22.17 |
| Resistance Level | $227.65 | $23.70 |
| Average True Range (ATR) | 8.44 | 0.90 |
| MACD | 1.57 | 0.05 |
| Stochastic Oscillator | 79.07 | 63.87 |
Price Performance
Historical ComparisonAbout RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.